CMD - Cantel Medical Corp.

NYSE - NYSE Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 4/8/2020
Current
1/31/202010/31/20197/31/20194/30/20191/31/2019
Market Cap (intraday) 5
1.42B2.77B3.10B3.85B2.88B3.40B
Enterprise Value 3
2.33B3.67B3.29B4.04B3.05B3.53B
Trailing P/E
68.8065.0655.2261.1139.1738.96
Forward P/E 1
14.5323.8126.6033.6724.3329.50
PEG Ratio (5 yr expected) 1
1.531.682.072.621.821.81
Price/Sales (ttm)
1.402.873.314.243.213.83
Price/Book (mrq)
1.963.784.695.884.495.46
Enterprise Value/Revenue 3
2.3012.7412.7916.8613.3315.71
Enterprise Value/EBITDA 6
21.37132.78111.47153.94118.7095.63

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 3-53.40%
S&P500 52-Week Change 3-7.77%
52 Week High 393.87
52 Week Low 320.81
50-Day Moving Average 346.72
200-Day Moving Average 364.41

Share Statistics

Avg Vol (3 month) 3567.79k
Avg Vol (10 day) 3605.75k
Shares Outstanding 542.14M
Float 37.04M
% Held by Insiders 111.16%
% Held by Institutions 1105.11%
Shares Short (Mar 12, 2020) 45.15M
Short Ratio (Mar 12, 2020) 49.54
Short % of Float (Mar 12, 2020) 413.57%
Short % of Shares Outstanding (Mar 12, 2020) 412.22%
Shares Short (prior month Feb 13, 2020) 45.36M

Dividends & Splits

Forward Annual Dividend Rate 40.21
Forward Annual Dividend Yield 40.62%
Trailing Annual Dividend Rate 30.20
Trailing Annual Dividend Yield 30.61%
5 Year Average Dividend Yield 40.20
Payout Ratio 441.84%
Dividend Date 3Jan 30, 2020
Ex-Dividend Date 4Jan 15, 2020
Last Split Factor 23:2
Last Split Date 3Jul 14, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2019
Most Recent Quarter (mrq)Jan 30, 2020

Profitability

Profit Margin 2.02%
Operating Margin (ttm)13.13%

Management Effectiveness

Return on Assets (ttm)5.71%
Return on Equity (ttm)3.01%

Income Statement

Revenue (ttm)1.01B
Revenue Per Share (ttm)24.13
Quarterly Revenue Growth (yoy)28.50%
Gross Profit (ttm)430.23M
EBITDA 184.54M
Net Income Avi to Common (ttm)20.5M
Diluted EPS (ttm)0.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)59.98M
Total Cash Per Share (mrq)1.44
Total Debt (mrq)968.47M
Total Debt/Equity (mrq)133.90
Current Ratio (mrq)2.15
Book Value Per Share (mrq)17.16

Cash Flow Statement

Operating Cash Flow (ttm)81.27M
Levered Free Cash Flow (ttm)26.7M